SpeakEasy revealed its plans to apply large scale commercial farming principles to national and international cannabis markets in 2020.
Aphria has received its EU GMP certification from the Malta Medicines Authority at its facility in Leamington, Ontario.
Maple Leaf Green World will be cultivating cannabigerol (CBG) enriched hemp seeds, a newly discovered, non-psychoactive cannabinoid.
Akerna has completed its acquisition of a majority interest in solo sciences, an anti-counterfeiting and consumer engagement technology company.
Aphria announced that its subsidiary, ARA - Avanti Rx Analytics, has received its EU GMP certification from the Malta Medicines...
Pyxus International announced its indirect subsidiary Figr Brands has launched a line of THC vape products in the Canadian marketplace.
InMed Pharmaceuticals confirmed that CBN is the active pharmaceutical ingredient in its two product candidates under development.